Newsroom

Blog

NeoGenomics Hurricane Ian Emergency Response

as of 6:00pm ET

 

Dear Valued Client,

Read More

NeoGenomics Lab Operations | Hurricane Ian

Important Announcement

NeoGenomics Lab Operations | Hurricane Ian

Read More

Orphan CDx assays

Drug development is rapidly outpacing our ability to bring companion diagnostics to market.

Read More

MultiOmyx 101: An Introduction to Multiplexing Technology

Cancer claims more than half a million lives each year in the United States alone.

Read More
Written By:
AnnaJunckerJensen.jpg
Anna Juncker-Jensen

Comprehensive Genomic Profiling (CGP) expands precision medicine’s utility

With the first TKI therapy Imatinib (Gleevec) targeting the fusion BCR-ABL1, approved by FDA in 2001, we have witnessed the birth of modern targeted therapy and personalized medicine.

Read More
Written By:
QinqinZha.jpg
Qinqin Zha

NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6

NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6, 2022.

Read More

Diagnostic Symposium

Join NeoGenomics for our upcoming Diagnostic Symposium on Tuesday, May 10, 9 to 10 a.m. PT.

Read More

Travelogue 2

On Saturday, March the 12th, after 28 days in China, I was finally allowed to travel to Suzhou.
 

Read More
Written By:
Charlotte Serra profile image
Charlotte Serra

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients